Company Filing History:
Years Active: 2021
Title: Kurt Lövgren: Innovator in Cholestyramine Formulations
Introduction
Kurt Lövgren is a notable inventor based in Mölnlycke, Sweden. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of cholestyramine granules.
Latest Patents
Lövgren holds a patent for "Cholestyramine granules, oral cholestyramine formulations and use thereof." This invention relates to small granules comprising cholestyramine, which have a high cholestyramine content and are stable enough to be coated with one or more coating layers. The invention also includes a multiparticulate drug delivery system that utilizes these granules. Furthermore, it describes an oral formulation designed for targeted delivery of cholestyramine to the colon, which consists of a plurality of cholestyramine granules coated with a colon release coating. This formulation is particularly useful in treating bile acid malabsorption and bile acid diarrhea. Kurt Lövgren has 1 patent to his name.
Career Highlights
Lövgren is associated with Albireo AB, a company focused on developing innovative therapies for liver and gastrointestinal diseases. His work has contributed to advancements in drug delivery systems and formulations.
Collaborations
Throughout his career, Kurt Lövgren has collaborated with notable colleagues, including Per-Göran Gillberg and Nils Ove Gustafsson. Their combined expertise has furthered research and development in the pharmaceutical field.
Conclusion
Kurt Lövgren's innovative work in cholestyramine formulations showcases his commitment to improving drug delivery systems. His contributions have the potential to significantly impact the treatment of gastrointestinal disorders.